Skip to main content
Premium Trial:

Request an Annual Quote

Arizona Foundation Awards $2.2M to UA, HTG to Create Chemical Genomics Center

NEW YORK (GenomeWeb News) - Science Foundation Arizona has awarded $2.2 million to the University of Arizona and High Throughput Genomics to create the Chemical Genomics and Translational Research Center, HTG said yesterday.
SFAz will give the collaborative effort $1 million this year and another $1 million next year. The award, which is granted under SFAz’s Strategic Research Group, also sets aside $171,500 as an institutional allowance to UA, the company said.
The CGTR will also receive “in-kind funding” from HTG and BIO5, a state-funded economic development and biotechnology development body. Including this support, the center’s funding could total as much as $6 million over the next two years, HTG said.
Research at CGTR will be led by David Galbraith, a professor of plant sciences at UA, and by Bruce Seligmann, HTG’s chief scientific officer. The center will be based in BIO5’s Thomas W. Keating Bioresearch Building on the UA campus.
HTG said it will work with the CGTR to further develop its quantitative nuclease protection assay “into a high density microarray to improve the quality and speed of biomarker and target identification, validation and subsequent screening and optimization of agricultural and pharmaceutical compounds.”
HTG said the qNPA platform will be “validated and applied to a diverse set of BIO5 projects” including one to identify agricultural chemicals that may lower the cost of making ethanol, and one that would use the technology to identify molecular changes that occur in cells when they become cancerous.
The terms of the collaboration call for HTG to commercialize any biomarkers and high-density array products developed for the qNPA platform, while UA will commercialize biomarkers and other technologies that are not based on the platform.  

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.